Page 2 - Global Consortium Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  TORONTO -- A new study has found that 82 per cent of people who were hospitalized due to COVID-19 experienced neurological symptoms. The study, conducted by the Global Consortium Study of Neurologic Dysfunction in COVID-19 and the European Academy of Neurology Neuro-COVID Registry, involved over 3,700 patients across 13 countries who were assessed between March and October 2020 for neurological complications related to COVID-19. Researchers report that neurological complications are widespread, and affected 82 per cent of patients who were hospitalized due to the disease. The average ...

Half of the patients had altered brain function or structure, and almost 1 in 5 were in a coma.

Design Cells / iStock Eight of 10 hospitalized COVID-19 patients developed neurologic complications and were six times more likely than their peers to die, according to early results from a global study published yesterday in JAMA Network Open. Many of the conditions were mild to moderate, but half of the patients had altered brain function or structure, and almost one in five were in a coma. Led by University of Pittsburgh researchers for the Global Consortium Study of Neurologic Dysfunction in COVID-19, the study involved 3,744 hospitalized adult COVID-19 patients at 28 centers in 13 count...

SHARE The Global Consortium Study of Neurologic Dysfunction in Covid-19 says hospital patients with clinically diagnosed neurological signs are six times more likely to die than those without. Read More "Very early on in the pandemic it became apparent that a good number of people who were sick enough to be hospitalised also developed neurological problems," said Dr Sherry Chou, lead author and associate professor of critical care medicine, neurology and neurosurgery at the University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Centre (UPMC). "A year later we a...

Date Time 80% of Hospitalized COVID Patients Have Neurological Issues Patients with clinically diagnosed neurological symptoms associated with COVID-19 are six times more likely to die in the hospital than those without the neurological complications, according to an interim analysis from the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID). A paper published today in JAMA Network Open presents early results of the global effort to gather information about the incidence, severity and outcomes of neurological manifestations of COVID-19 disease. “Very early on i...